|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analyst Conference Summaries |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sage Therapeutics
|
2022 | |||
Sage Therapeutics Q1 2022 |
Sage Therapeutics Q2 2022 |
Sage Therapeutics Q3 2022 |
|
May 3, 2022 | Aug. 2, 2022 | Nov. 8, 2022 | |
2021 | |||
Sage Therapeutics Q1 2021 |
Sage Therapeutics Q2 2021 |
Sage Therapeutics Q3 2021 |
Sage Therapeutics Q4 2021 |
May 4, 2021 | Aug. 3, 2021 | Nov. 2, 2021 | Feb. 24, 2022 |
2020 | |||
Sage Therapeutics Q3 2020 |
Sage Therapeutics Q4 2020 |
||
Nov. 5, 2020 | Feb. 24, 2021 |
Sage Therapeutics (SAGE) is a commercial stage biotechnology company specializing in therapies for brain disorders.
More Analyst Conference Pages:
AGEN |
AGIO |
ALNY |
ALXN |
AMAT |
AMGN |
BIIB |
BMY |
CDTX |
CLDX |
EPZM |
GILD |
GLYC |
ILMN |
INO |
IONS |
ISRG |
MCHP |
MRNA |
PLX |
REGN |
RNA |
SANA |
SGEN |
SYRS |
VBLT |
VRTX |
VSTM |
WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2022 William P. Meyers